Author:
Ommurugan Balaji,Rao Vanishree
Abstract
Migraine characterized by recurrent headache episodes presents with aura or without. Various treatment modalities ranging from 5-HT1B/1D agonists, nonsteroidal anti-inflammatory drugs (NSAIDs), to steroids are available for acute treatment of migraine. Prophylaxis for chronic cases usually encompasses β blockers, calcium channel blockers, and antiepileptics. Many nutraceutical preparations are helpful in migraine, including riboflavin and vitamin B12. This review focuses on the newer agents available for treatment of migraine with some insights into their clinical trials.
Reference73 articles.
1. Timothy et al. Impact of weather conditions on migraine in north eastern Nigeria. International Journal of Pharmacy and Pharmaceutical Sciences. 2011;3(3):133-136
2. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163-2196
3. Natoli JL, Manack A, Dean B, Butler Q , Turkel CC, Stovner L, et al. Global prevalence of chronic migraine: A systematic review. Cephalalgia. 2009;30(5):599-609
4. Abeer AK, Gihan SL. Flash dissolving sublingual almotriptan malate lyotabs for management of migraine. International Journal of Pharmacy and Pharmaceutical Sciences. 2017;9(1):125-131
5. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24(Suppl 1):9-160